1. Home
  2. FINV vs VERA Comparison

FINV vs VERA Comparison

Compare FINV & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$5.04

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$33.81

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
VERA
Founded
2007
2016
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FINV
VERA
Price
$5.04
$33.81
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$11.55
$61.71
AVG Volume (30 Days)
1.7M
1.7M
Earning Date
11-19-2025
11-05-2025
Dividend Yield
5.72%
N/A
EPS Growth
27.76
N/A
EPS
1.50
N/A
Revenue
$1,969,555,571.00
N/A
Revenue This Year
$11.56
N/A
Revenue Next Year
$8.06
N/A
P/E Ratio
$3.33
N/A
Revenue Growth
8.81
N/A
52 Week Low
$4.70
$18.53
52 Week High
$11.08
$51.27

Technical Indicators

Market Signals
Indicator
FINV
VERA
Relative Strength Index (RSI) 33.21 66.36
Support Level $4.70 $27.19
Resistance Level $5.29 $29.90
Average True Range (ATR) 0.25 2.15
MACD -0.04 0.57
Stochastic Oscillator 19.82 93.18

Price Performance

Historical Comparison
FINV
VERA

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: